Ilenia Calcaterra: Clinical Relevance of Persistent Pain in Emicizumab-Treated Haemophilia A
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared a post on LinkedIn:
“Honored to have presented our work during the free paper session at the WFH 2026 World Congress in Kuala Lumpur.
In this study, we explored the multidimensional pain experience of adults with severe haemophilia
A receiving Emicizumab prophylaxis using the Multidimensional Haemophilia Pain Questionnaire (MHPQ).
Our findings highlight an important clinical message: even in the era of highly effective bleed prevention, pain remains prevalent and functionally relevant, suggesting that haemophilia-related pain is not exclusively bleeding-driven and deserves structured, multidimensional assessment in routine care.
Grateful for the opportunity to share our data, for the stimulating scientific discussion, and for the chance to contribute to ongoing research aimed at improving the lives of people with haemophilia.”
Other posts featuring Ilenia Calcaterra on Hemostasis Today.
-
Nov 3, 2026, 16:57Ahmed Alotaibi: Which Macrophage Receptor ‘eats’ anti-E and Anti-K Coated RBCs?
-
Nov 3, 2026, 16:53Jan Sloves: Key Factors for Achieving Durable Patency in Advanced Venous Stenting
-
Nov 3, 2026, 16:45Nina Weber: Review on Kidney Injury After Stem Cell Transplantation
-
Nov 3, 2026, 16:36Chris Baugh: EMplify Podcast Explores Antithrombotic Associated Bleeding in the Emergency Department
-
Nov 3, 2026, 16:32Carlo Zaninetti: Highlights from the XXIX Congress of the Italian Society on Haemostasis and Thrombosis
-
Nov 3, 2026, 15:10Lady Joan Branson’s Story – The Hidden Danger of Hospitalization
-
Nov 3, 2026, 14:38Emna Hammami: Exploring the Haemophilia Treatment Landscape at the EHC New Technologies Conference
-
Nov 3, 2026, 14:20EHC Marks the Final Edition of Its New Technologies Conference in Bucharest
-
Nov 3, 2026, 14:15Rhiannon Morris: Awarded CASS Foundation Travel Grant to Present Research at ASH 2026